Suspension
Clav-Win
Amoxycillin 200 mg & Potassium Clavulanate 28.5 mg Suspension
Product Overview
Distinctly superior beta-lactamase inhibitor combination offering broad-spectrum efficacy for tonsillopharyngitis, sinusitis, bronchitis, dental, and soft tissue infections.
Product Compliance Notice: Sourced strictly from licensed third-party pharmaceutical manufacturers. For institutional healthcare procurement and clinical inquiries only. Does not constitute consumer self-medication guidance.
PORTFOLIO
Related Formulations
Additional pharmaceutical products available for hospital and institutional supply.
